Daily Values

Growth Metrics

Others

Ratios

Asset Utilization Ratio Assets Average EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales

Xilio Therapeutics (XLO) Equity Average (2024 - 2025)

Xilio Therapeutics' Equity Average history spans 2 years, with the latest figure at -$513000.0 for Q3 2025.